Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain-Barré
Rutgers reports first instance of COVID-19 triggering recurrent Guillain-Barré Syndrome
Pediatric ER saw steep drop in asthma visits during spring COVID-19 lockdown
A new study published online in the Annals of the American Thoracic Society discusses a steep drop off from prior
Pets, touch and COVID-19: Why our furry friends are lifesavers
Lockdowns, job losses and social isolation have been the hallmarks of 2020 as COVID-19 tightens its grip on the world,
Pictured: A doctor hugged a distraught elderly coronavirus patient on Thanksgiving, after warning the public America is headed for its ‘darkest days’ over Christmas
A photo of Dr. Joseph Varon, chief of staff at United Memorial Medical Center in Houston, cradling a COVID-19 patient
Another Study Casts Doubt on ‘Convalescent Plasma’ as COVID-19 Treatment
WEDNESDAY, Nov. 25, 2020 — Early in the COVID-19 pandemic, anecdotal reports suggested that infusing very sick patients with the
Tracking COVID-19 trends in hard-hit states
Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S. Researchers
How language barriers can add anguish and complicate care for COVID-19 patients who don’t speak English
Even though Rodolfo Reyes’ partner died of COVID-19 complications more than six months ago, he still buys her flowers almost
Covid-19: Russia’s Sputnik V vaccine for coronavirus is 95% effective, cheaper than others, say developers
The developers of Sputnik V coronavirus vaccine announced on Tuesday that it had an efficacy rate or 95 per cent
Youngest COVID-19 patients most likely to avoid severe illness, recover with care
In a comprehensive review of research studies looking at infections from SARS-CoV-2—the virus that causes COVID-19—in infants less than three
X-ray study explores potential of hepatitis C drugs to treat COVID-19
Experiments led by researchers at the Department of Energy’s Oak Ridge National Laboratory have determined that several hepatitis C drugs